ANSWER: Whether stents are beneficial in people with stable coronary artery disease remains somewhat controversial. Although ...

Coronary artery disease (CAD) is common in patients with cirrhosis, but cirrhosis itself is not significantly associated with an increased CAD risk.

Trientine hydrochloride is under clinical development by Innolife and currently in Phase II for Coronary Artery Disease (CAD) (Ischemic Heart Disease).

This surge is primarily driven by the growing demand for minimally invasive procedures to treat cardiovascular diseases, which are on ...

The following is a summary of “Impact of frailty on outcomes following coronary artery bypass grafting: a systematic review ...

PRNewswire Tampa Florida [US] January 7 Concept Medical Inc a global leader in innovative drug-delivery technology proudly ...

Both atherosclerosis and arteriosclerosis cause artery damage, but the way this happens differs. Here’s what you need to know ...

Surviving a severe case of COVID-19 may be just as dangerous for your heart as having cardiovascular disease - even if you were perfectly healthy before infection.

Post-PCI LVEF recovery varies by CAD type, with STEMI patients showing the most significant survival benefits.

announced today that it will cease the production and sales of its peripheral artery disease (PAD) products to concentrate on developing devices for treating coronary artery disease (CAD).

The company is working on treatments for a form of heart pain. Its gene therapy, XC001, will also be tested as a supplemental ...